1Y Close · As of Aug 26, 2026
Sugentech operates in the Pharmaceuticals sector.
Legal name: Sugentech, Inc.
In fiscal year 2025, Sugentech (253840) reported revenue of 9.4 billion KRW, down 6.7% from 10.1 billion KRW a year earlier.
Operating profit was -18.8 billion KRW and net income was -23.5 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 72.5 billion KRW, with a P/B of 0.95.
These figures can be verified in the DART filing (receipt no. 20260318001334).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 9.4B | -18.8B | -23.5B |
| 2024 | 10.1B | -22.0B | -15.4B |
| 2023 | 7.1B | -22.8B | -17.4B |
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |